RenovoRx
RNXT
31 hedge funds and large institutions have $9.04M invested in RenovoRx in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
24% more funds holding
Funds holding: 25 → 31 (+6)
4.59% less ownership
Funds ownership: 24.04% → 19.45% (-4.6%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
22% less capital invested
Capital invested by funds: $11.6M → $9.04M (-$2.54M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$144K |
| 2 |
Renaissance Technologies
New York
|
+$73.4K |
| 3 |
BL
Bleichroeder LP
New York
|
+$45.9K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$37.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$1.2M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.01M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$69.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$34.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$28.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $3.89K | +$3.64K | +3,060 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $2.02K | +$1.89K | +1,589 | New |
|
|
28
UBS Group
Zurich,
Switzerland
| $852 | -$34.9K | -29,338 | -98% |
|
29
Bank of America
Charlotte,
North Carolina
| $371 | -$78 | -66 | -18% |
|
30
Barclays
London,
United Kingdom
| $150 | +$140 | +118 | New |
|
|
SS
31
SBI Securities
Tokyo,
Japan
| $3 | +$2 | +2 | New |
|
|
TSS
32
Two Sigma Securities
New York
| – | -$28.7K | -21,835 | Closed |
|
|
ACM
33
ADAR1 Capital Management
Austin,
Texas
| – | -$26.2K | -19,889 | Closed |
|
RNXT Hedge Fund Activity: Q3 2025 in Review
31 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q3 2025, worth a combined $9.04M — down 22% from $11.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RNXT positions and 2 closed out — a net gain of 6 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $144K. The largest seller was AWM Investment Company, cutting an estimated $1.2M.
- 31 institutional investors held RenovoRx (RNXT) as of Q3 2025, up from 25 in Q2 2025.
- Funds reported $9.04M of RenovoRx stock for Q3 2025, down 22% quarter-over-quarter.
- 8 funds opened new RenovoRx positions in Q3 2025 and 2 closed out, a net change of +6 holders.
- The largest RenovoRx buyer in Q3 2025 was Citadel Advisors, an estimated $144K added.
- The largest RenovoRx seller in Q3 2025 was AWM Investment Company, an estimated $1.2M sold.
Based on aggregated 13F filings for Q3 2025.